RecallRadar

FDA Drug recall D-1335-2022

Zynrelef (bupivacaine and meloxicam), 400 mg bupivacaine and 12 mg meloxicam single dose application, packaged in a kit, Rx only, Manufactu…

On 2022-08-24 the FDA classified a Class III recall of Zynrelef (bupivacaine and meloxicam), 400 mg bupivacaine and 12 mg meloxicam single dose application, packaged in a kit, Rx only, Manufactu… by Heron Therapeutics, citing defective Delivery System: An incorrect 10 mL (12 mL) Luer (slip) syringe packaged in one lot of Zynrelef 400 mg/12 mg kit.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1335-2022
ClassificationClass III
Statusterminated
Initiated2022-08-02
Published2022-08-24
Last updated2026-09-13 11:52 UTC
CompanyHeron Therapeutics
DistributionUS

Product

Zynrelef (bupivacaine and meloxicam), 400 mg bupivacaine and 12 mg meloxicam single dose application, packaged in a kit, Rx only, Manufactured for Heron Therapeutics, Inc., San Diego, CA, NDC 47426-301-02

Reason

Defective Delivery System: An incorrect 10 mL (12 mL) Luer (slip) syringe packaged in one lot of Zynrelef 400 mg/12 mg kit

Identifiers

ndc47426-301-06
ndc47426-301-04
ndc47426-301-02
ndc47426-302-06
ndc47426-302-04
ndc47426-302-02
ndc47426-303-05
ndc47426-303-03
ndc47426-303-01
ndc47426-304-05
ndc47426-304-03
ndc47426-304-01
ndc47426-501-04
ndc47426-501-02
ndc47426-502-04
ndc47426-502-02
ndc47426-503-03
ndc47426-503-01
ndc47426-504-03
ndc47426-504-01
code_infoLot #: 01126739, Exp 7/31/2023

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1335-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.